XML 33 R21.htm IDEA: XBRL DOCUMENT v3.6.0.2
Note 13 - Employee Benefit Plans
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE
13:
     EMPLOYEE BENEFIT PLANS
 
Equity Plans
 
On
May
27,
2015,
the Company’s stockholders voted to approve the Guaranty Federal Bancshares, Inc.
2015
Equity Plan
(the”2015
Plan”). The Plan provides for the grant of up to
250,000
shares of Common Stock under equity awards including stock options, stock awards, restricted stock, stock appreciation rights, performance units, or other equity-based awards payable in cash or stock to key employees and directors of the Company and the Bank. As of
December
31,
2016,
restricted stock for
27,645
shares of Common Stock has been granted under the Plan.
 
On
May
26,
2010,
the Company’s stockholders voted to approve the Guaranty Federal Bancshares, Inc.
2010
Equity Plan
(the”2010
Plan”). The Plan provides for the grant of up to
200,000
shares of Common Stock under equity awards including stock options, stock awards, restricted stock, stock appreciation rights, performance units, or other equity-based awards payable in cash or stock to key employees and directors of the Company and the Bank. As of
December
31,
2016,
non-incentive stock options for
25,000
shares and restricted stock for
139,330
shares of Common Stock have been granted under the Plan.
 
In addition, the Company established
four
stock option plans for the benefit of certain directors, officers and employees of the Company and its subsidiary. A committee of the Company’s Board of Directors administers the plans. The stock options under these plans
may
be either incentive stock options or nonqualified stock options. Incentive stock options can be granted only to participants who are employees of the Company or its subsidiary. The option price must not be less than the market value of the Company stock on the date of grant. All options expire no later than
ten
years from the date of grant. The options vest at the rate of
20%
per year over a
five
-year period.
 
The tables below summarize transactions under the Company’s equity plans:
 
Stock Options
 
 
   
Number of shares
         
   
Incentive Stock Option
   
Non-Incentive Stock Option
   
Weighted Average Exercise Price
 
Balance outstanding as of January 1, 2014
   
168,100
     
121,000
     
16.54
 
Granted
   
-
     
-
     
-
 
Exercised
   
(25,100
)    
(14,500
)    
5.33
 
Forfeited
   
(2,700
)    
(24,000
)    
19.03
 
Balance outstanding as of December 31, 2014
   
140,300
     
82,500
     
18.23
 
Granted
   
-
     
-
     
-
 
Exercised
   
(10,800
)    
(25,000
)    
5.22
 
Forfeited
   
(38,000
)    
-
     
25.19
 
Balance outstanding as of December 31, 2015
   
91,500
     
57,500
     
19.58
 
Granted
   
-
     
-
     
 
 
Exercised
   
(11,500
)    
(5,000
)    
5.20
 
Forfeited
   
(20,000
)    
-
     
28.28
 
Balance outstanding as of December 31, 2016
   
60,000
     
52,500
    $
20.15
 
Options exercisable as of December 31, 2016
   
60,000
     
52,500
    $
20.15
 
 
Restricted Stock
 
   
Number of shares
   
Weighted
Average
Grant-
Date Price
 
Balance of shares non-vested as of January 1, 2014
   
27,629
    $
7.39
 
Granted
   
34,562
     
10.99
 
Vested
   
(31,688
)    
8.55
 
Forfeited
   
-
     
-
 
Balance of shares non-vested as of December 31, 2014
   
30,503
     
10.26
 
Granted
   
28,951
     
14.78
 
Vested
   
(15,083
)    
11.64
 
Forfeited
   
(894
)    
12.26
 
Balance of shares non-vested as of December 31, 2015
   
43,477
     
12.75
 
Granted
   
24,679
     
15.01
 
Vested
   
(7,201
)    
13.13
 
Forfeited
   
-
     
-
 
Balance of shares non-vested as of December 31, 2016
   
60,955
    $
13.62
 
 
 
As of
December
31,
2016,
total outstanding stock options of
112,500
had a remaining contractual life of
1.35
years.
 
The total intrinsic value of outstanding stock options was
$660,120
and
$565,025
at
December
31,
2016
and
2015,
respectively. The total intrinsic value of outstanding exercisable stock options was
$660,120
and
$565,025
at
December
31,
2016
and
2015,
respectively. The fair value of options vested during
2016,
2015,
and
2014
was
$0,
$143,350
and
$361,517,
respectively.
 
In
February
2016,
the Company granted
9,336
shares of restricted stock to directors that have a
one
year cliff vesting. In
February
2015
and
2014,
the Company granted
8,281
and
11,242
of restricted stock to directors that was fully vested and thus, expensed in full during the year ended
December
31,
2015
and
2014,
respectively. In
June
2015,
the Company granted
966
shares of restricted stock to directors that have a cliff vesting at the end of
three
years. The expense is being recognized over the applicable vesting period. The expense relating to these awards for the years ended
December
31,
2016,
2015
and
2014
was
$126,032,
$124,910
and
$122,538,
respectively.
 
During
2016,
the Company granted
15,343
shares of restricted stock to officers that have a cliff vesting at the end of
three
years. During
2015,
the Company granted
19,704
shares of restricted stock to officers that have a cliff vesting at the end of
three
years. During
2014,
the Company granted
23,320
shares of restricted stock to officers that have a cliff vesting at the end of
three
years. The expense is being recognized over the applicable vesting period. The expense relating to these awards for the years ended
December
31,
2016,
2015
and
2014
was
$267,606,
$176,644
and
$102,099,
respectively.
 
Total stock-based compensation expense is comprised of expense for restricted stock awards and stock options. Expense recognized for the years ended
December
31,
2016,
2015
and
2014
was
$393,638,
$297,295
and
$254,340,
respectively. As of
December
31,
2016,
there was
$287,443
of unrecognized compensation expense related to nonvested restricted stock awards, which will be recognized over the remaining vesting periods.